EDGAR Filing Documents for 0001104659-18-053799

Form 8-K - Current report:

SEC Accession No. 0001104659-18-053799

Filing Date

2018-08-28

Accepted

2018-08-28 07:45:42

Documents

Period of Report

2018-08-28

Items

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a18-21158_18k.htm	8-K	23999
2	EX-99.1	a18-21158_1ex99d1.htm	EX-99.1	10369
3	GRAPHIC	g211581mmi001.jpg	GRAPHIC	3085
	Complete submission text file	0001104659-18-053799.txt		39923

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053

Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200

Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 8-K | Act: 34 | File No.: 001-37569 | Film No.: 181040132
SIC: 2834 Pharmaceutical Preparations